Gene: RAB28
Official Full Name: RAB28, member RAS oncogene familyprovided by HGNC
Gene Summary: This gene encodes a member of the Rab subfamily of Ras-related small GTPases. The encoded protein may be involved in regulating intracellular trafficking. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 9 and X. [provided by RefSeq, Apr 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33294 | RAB28 Knockout cell line (HeLa) | Human | RAB28 | 1:3~1:6 | Negative | Online Inquiry |
KO33295 | RAB28 Knockout cell line (HCT 116) | Human | RAB28 | 1:2~1:4 | Negative | Online Inquiry |
KO33296 | RAB28 Knockout cell line (HEK293) | Human | RAB28 | 1:3~1:6 | Negative | Online Inquiry |
KO33297 | RAB28 Knockout cell line (A549) | Human | RAB28 | 1:3~1:4 | Negative | Online Inquiry |
RAB28 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the in-depth study of the RAB28 gene, which encodes a member of the RAB family of small GTPases involved in intracellular trafficking processes. By employing CRISPR/Cas9 gene editing technology, these knockout cell lines effectively disable the RAB28 gene, allowing researchers to investigate the gene's physiological roles and the consequences of its disruption.
The primary function of the RAB28 protein is linked to vesicle transport and membrane trafficking, playing a critical role in the regulation of exocytosis and endocytosis mechanisms. By providing a model in which this gene is inactivated, researchers can observe changes in cellular morphology, growth patterns, and signaling cascades, thus yielding insights into its biological implications. This is especially valuable for studies focused on diseases where RAB proteins have been implicated, such as neurodegenerative disorders and cancer.
One of the significant advantages of RAB28 Gene Knockout Cell Lines over traditional models lies in their genetic precision and reliability. Unlike chemical inhibitors or RNA interference strategies, which may have off-target effects, these knockout lines provide a clean genetic background devoid of the RAB28 gene, ensuring that the observed phenotypes are directly attributed to the loss of this specific protein. Furthermore, the ease of integration into high-throughput screening workflows accelerates research timelines and enhances productivity.
For researchers, clinicians, and biotechnology professionals, the ability to explore the functional consequences of gene knockout with high specificity positions RAB28 Gene Knockout Cell Lines as a valuable tool in the quest to understand cellular mechanisms in health and disease. As part of our commitment to advancing scientific discovery, our company utilizes state-of-the-art gene editing technologies to offer products critical for cutting-edge research, underpinned by a robust expertise in genetic models and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.